Search hospitals > Tennessee > Knoxville

Baptist Regional Cancer Center - Knoxville

Claim this profile
Knoxville, Tennessee 37920
Global Leader in Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Colorectal Cancer
Conducts research for Cancer
Conducts research for Breast Cancer
64 reported clinical trials
2 medical researchers
Photo of Baptist Regional Cancer Center - Knoxville in KnoxvillePhoto of Baptist Regional Cancer Center - Knoxville in KnoxvillePhoto of Baptist Regional Cancer Center - Knoxville in Knoxville

Summary

Baptist Regional Cancer Center - Knoxville is a medical facility located in Knoxville, Tennessee. This center is recognized for care of Lung Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer, Cancer, Breast Cancer and other specialties. Baptist Regional Cancer Center - Knoxville is involved with conducting 64 clinical trials across 77 conditions. There are 2 research doctors associated with this hospital, such as Radhakrishnan Ramchandren, M.D. and Wahid Hanna.

Area of expertise

1Lung Cancer
Global Leader
Baptist Regional Cancer Center - Knoxville has run 15 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
PD-L1 positive
2Non-Small Cell Lung Cancer
Baptist Regional Cancer Center - Knoxville has run 9 trials for Non-Small Cell Lung Cancer.

Top PIs

Radhakrishnan Ramchandren, M.D.University of Tennessee3 years of reported clinical research
Studies Lymphoma
Studies Hodgkin's Lymphoma
7 reported clinical trials
13 drugs studied
Wahid HannaUniversity of Tennessee SC4 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
3 reported clinical trials
8 drugs studied

Clinical Trials running at Baptist Regional Cancer Center - Knoxville

Follicular Lymphoma
Lung Cancer
Lymphoma
Non-Hodgkin's Lymphoma
Image of trial facility.

Tazemetostat + Lenalidomide + Rituximab

for Follicular Lymphoma

The participants of this study would have relapsed/refractory follicular lymphoma. Follicular lymphoma is a type of blood cancer. It is referred to as 'relapsed' when the disease has come back after a period of improvement after that follows a treatment regimen and 'refractory' when treatment no longer works. Stage 1 of this trial will study the safety and the level that adverse effects of each of the study drug combinations can be tolerated (known as tolerability). It is also designed to establish a recommended study drug dosage for stage 2 and 3. Stage 1 of the study is completed. Stages 2 and 3 will evaluate and compare how long participants live without their disease getting worse when receiving the study drug in combination with other drug treatment versus the placebo (dummy drug) in combination with other drug treatment.
Recruiting1 award Phase 34 criteria

Similar Hospitals nearby

Select from list below to view details

Frequently asked questions

What kind of research happens at Baptist Regional Cancer Center - Knoxville?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security